Lv31
390 积分 2023-04-04 加入
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Developing cell therapies for lupus
2个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
2个月前
已完结
The race to reset autoimmune diseases
2个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
2个月前
已完结
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
2个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
2个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
3个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
3个月前
已完结
皖公网安备34019202002308
